| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8633433 | Neuropeptides | 2017 | 7 Pages | 
Abstract
												In the MIA OA pain model, neuropeptide modulation appears early, and confirms the central nervous system to be an attractive target for OA pain quantification. The relationship of neuropeptide release with severity of cartilage lesions and functional assessment are promising and need further validation.
											Keywords
												NeuropeptidomicsSTTMIAATF-3PWTCGRPv/vw/vpaw withdrawal thresholdProbabilityOsteoarthritisstandard deviationbradykininvolume/volumestandard error of the meanPainDAYSomatostatinnociceptionNuclear factor-kappa BActivating transcription factor-3LidocaineSubstance PSEMIntra-articularweight/volumemonosodium iodoacetate
												Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Endocrinology
												
											Authors
												Colombe Otis, Martin Guillot, Maxim Moreau, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Francis Beaudry, Eric Troncy, 
											